Treace Medical Concepts, Inc. (TMCI) Tops Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $50.2 million versus the consensus estimate of $49.66 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Ross Stores, Inc. (ROST) PT Raised to $239 at UBS on Q2 Earnings Beat
• Syndax Pharmaceuticals (SNDX) PT Lowered to $33 at UBS as Revuforj New Starts Decline